Cargando…
Aromatase inhibitor-induced modulation of breast density: clinical and genetic effects
BACKGROUND: Change in breast density may predict outcome of women receiving adjuvant hormone therapy for breast cancer. We performed a prospective clinical trial to evaluate the impact of inherited variants in genes involved in oestrogen metabolism and signalling on change in mammographic percent de...
Autores principales: | Henry, N L, Chan, H-P, Dantzer, J, Goswami, C P, Li, L, Skaar, T C, Rae, J M, Desta, Z, Khouri, N, Pinsky, R, Oesterreich, S, Zhou, C, Hadjiiski, L, Philips, S, Robarge, J, Nguyen, A T, Storniolo, A M, Flockhart, D A, Hayes, D F, Helvie, M A, Stearns, V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817329/ https://www.ncbi.nlm.nih.gov/pubmed/24084768 http://dx.doi.org/10.1038/bjc.2013.587 |
Ejemplares similares
-
Lack of association between oestrogen receptor polymorphisms and change in bone mineral density with tamoxifen therapy
por: Henry, N L, et al.
Publicado: (2010) -
Whole Genome Amplification of DNA for Genotyping Pharmacogenetics Candidate Genes
por: Philips, Santosh, et al.
Publicado: (2012) -
Patient-Reported Outcomes and Early Discontinuation in Aromatase Inhibitor-Treated Postmenopausal Women With Early Stage Breast Cancer
por: Kadakia, Kunal C., et al.
Publicado: (2016) -
Inflammatory cytokines and aromatase inhibitor-associated musculoskeletal syndrome: a case–control study
por: Henry, N L, et al.
Publicado: (2010) -
Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in post-menopausal patients with breast cancer
por: Hertz, Daniel L., et al.
Publicado: (2016)